Literature DB >> 25624966

A rare cause of childhood renal cysts: Xp11.2 translocation renal cell carcinoma.

Hakan Taşkınlar1, Dinçer Avlan1, Çağlar Çıtak1, Ayşe Polat1, Ali Naycı1.   

Abstract

Pediatric renal cysts are rare, usually asymptomatic and incidentally detected in children. Cyst associated renal cell carcinoma (RCC) or cystic RCC is extremely rare in children. Bosniak classification system has been accepted for the management of cystic renal masses. Xp11.2 translocation RCC is a recently classified distinct subtype and usually affects children and adolescents. We report the case of a 10-year-old girl with Xp11.2 translocation RCC from a cyst of the right kidney.

Entities:  

Year:  2015        PMID： 25624966      PMCID： PMC4301968          DOI： 10.5489/cuaj.2321

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


  16 in total

Review 1.  Distinctive neoplasms characterised by specific chromosomal translocations comprise a significant proportion of paediatric renal cell carcinomas.

Authors:  Pedram Argani; Marc Ladanyi
Journal:  Pathology       Date:  2003-12       Impact factor: 5.306

Review 2.  An update of the Bosniak renal cyst classification system.

Authors:  Gary M Israel; Morton A Bosniak
Journal:  Urology       Date:  2005-09       Impact factor: 2.649

Review 3.  Translocation carcinomas of the kidney.

Authors:  Pedram Argani; Marc Ladanyi
Journal:  Clin Lab Med       Date:  2005-06       Impact factor: 1.935

Review 4.  Pediatric renal cell carcinoma.

Authors:  Justin E Sausville; David J Hernandez; Pedram Argani; John P Gearhart
Journal:  J Pediatr Urol       Date:  2009-05-14       Impact factor: 1.830

5.  TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition.

Authors:  Masumi Tsuda; Ian J Davis; Pedram Argani; Neerav Shukla; Gael G McGill; Makoto Nagai; Tsuyoshi Saito; Marick Laé; David E Fisher; Marc Ladanyi
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

Review 6.  Rapid development of metastatic Xp11 translocation renal cell carcinoma in a girl treated for neuroblastoma.

Authors:  Ryan C Hedgepeth; Ming Zhou; Jonathan Ross
Journal:  J Pediatr Hematol Oncol       Date:  2009-08       Impact factor: 1.289

7.  Risk assessment of incidentally detected complex renal cysts in children: potential role for a modification of the Bosniak classification.

Authors:  M Chad Wallis; Armando J Lorenzo; Walid A Farhat; Darius J Bägli; Antoine E Khoury; Joao L Pippi Salle
Journal:  J Urol       Date:  2008-05-21       Impact factor: 7.450

8.  Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.

Authors:  Pedram Argani; Priti Lal; Brian Hutchinson; Man Yee Lui; Victor E Reuter; Marc Ladanyi
Journal:  Am J Surg Pathol       Date:  2003-06       Impact factor: 6.394

9.  Renal cell carcinoma in the pediatric population: Results from the California Cancer Registry.

Authors:  Jonathan Silberstein; Julia Grabowski; Sidney L Saltzstein; Christopher J Kane
Journal:  Pediatr Blood Cancer       Date:  2009-02       Impact factor: 3.167

10.  A phase II trial of human recombinant interleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A Childrens Cancer Group study.

Authors:  M Bauer; G H Reaman; J A Hank; M S Cairo; P Anderson; B R Blazar; S Frierdich; P M Sondel
Journal:  Cancer       Date:  1995-06-15       Impact factor: 6.860
View more
  2 in total

1.  Imaging hallmark of Xp11.2 translocation renal cell carcinoma.

Authors:  Binit Sureka; Kalpana Bansal; Ankur Arora
Journal:  Can Urol Assoc J       Date:  2015-08-10       Impact factor: 1.862

2.  Factors Associated with Survival From Xp11.2 Translocation Renal Cell Carcinoma Diagnosis-A Systematic Review and Pooled Analysis.

Authors:  Yuqing Wu; Saisai Chen; Minhao Zhang; Kuangzheng Liu; Jibo Jing; Kehao Pan; Lihua Zhang; Bin Xu; Xiaoming Lu; Ming Chen
Journal:  Pathol Oncol Res       Date:  2021-03-30       Impact factor: 3.201
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.